The effectiveness of superficial versus deep dry needling or acupuncture for reducing pain and disability in individuals with spine-related painful conditions: a systematic review with meta-analysis
Abstract:Objective: The purpose of this systematic review was to evaluate the effects of deep versus superficial dry needling or acupuncture on pain and disability for spine-related painful conditions. A secondary purpose was to account for the differences of needling location in relation to the painful area. Methods: This PROSPERO (#CRD42018106237) registered review found 691 titles through a multi-database search. Following a comprehensive search, 12 manuscripts were included in the systematic review and 10 in the me… Show more
“…Although several invasive procedures have been compared ( e.g. , DN with MTrP infiltration (with no significant differences between the methods)[ 31 ], and superficial vs deep DN)[ 32 ], the available evidence comparing DN with percutaneous electrolysis applied to MTrPs is limited. To our knowledge, only one clinical trial has compared percutaneous electrolysis and DN in patients with temporomandibular disorders[ 17 ].…”
BACKGROUND
Unilateral patellofemoral pain syndrome (PFPS) is the most frequently diagnosed knee condition in populations aged < 50 years old. Although the treatment of myofascial trigger points (MTrPs) is a common and effective tool for reducing pain, previous studies showed no additional benefits compared with placebo in populations with PFPS. Percutaneous electrolysis is a minimally invasive approach frequently used in musculotendinous pathologies which consists of the application of a galvanic current through dry needling (DN).
AIM
To evaluate changes in sensitivity, knee pain perception and perceived pain during the application of these three invasive techniques.
METHODS
A triple-blinded, pilot randomized controlled trial was conducted on fifteen patients with unilateral PFPS who were randomized to the high-intensity percutaneous electrolysis (HIPE) experimental group, low-intensity percutaneous electrolysis (LIPE) experimental group or DN active control group. All interventions were conducted in the most active MTrP, in the rectus femoris muscle. The HIPE group received a 660 mA galvanic current for 10 s, the LIPE group 220 mA × 30 s and the DN group received no galvanic current. The MTrP and patellar tendon pain pressure thresholds (PPTs) and subjective anterior knee pain perception (SAKPP) were assessed before, after and 7 d after the single intervention. In addition, perceived pain during the intervention was also assessed.
RESULTS
Both groups were comparable at baseline as no significant differences were found for age, height, weight, body mass index, PPTs or SAKPP. No adverse events were reported during or after the interventions. A significant decrease in SAKPP (both HIPE and LIPE,
P
< 0.01) and increased patellar tendon PPT (all,
P
< 0.001) were found, with no differences between the groups (VAS: F = 0.30; η
2
= 0.05;
P
> 0.05; tendon PPT immediate effects: F = 0.15; η
2
= 0.02;
P
> 0.05 and tendon PPT 7-d effects: F = 0.67; η
2
= 0.10;
P
> 0.05). A significant PPT increase in rectus femoris MTrP was found at follow-up in both the HIPE and LIPE groups (both,
P
< 0.001) with no differences between the groups (immediate effects: F= 1.55; η
2
= 0.20;
P
> 0.05 and 7-d effects: F = 0.71; η
2
= 0.10;
P
> 0.05). Both HIPE and LIPE interventions were considered less painful compared with DN (F = 8.52; η
2
= 0.587;
P
< 0.01).
CONCLUSION
HIPE and LIPE induce PPT changes in MTrPs and patellar tendon and improvements in SAKPP, and seem to produce less pain during the intervention compa...
“…Although several invasive procedures have been compared ( e.g. , DN with MTrP infiltration (with no significant differences between the methods)[ 31 ], and superficial vs deep DN)[ 32 ], the available evidence comparing DN with percutaneous electrolysis applied to MTrPs is limited. To our knowledge, only one clinical trial has compared percutaneous electrolysis and DN in patients with temporomandibular disorders[ 17 ].…”
BACKGROUND
Unilateral patellofemoral pain syndrome (PFPS) is the most frequently diagnosed knee condition in populations aged < 50 years old. Although the treatment of myofascial trigger points (MTrPs) is a common and effective tool for reducing pain, previous studies showed no additional benefits compared with placebo in populations with PFPS. Percutaneous electrolysis is a minimally invasive approach frequently used in musculotendinous pathologies which consists of the application of a galvanic current through dry needling (DN).
AIM
To evaluate changes in sensitivity, knee pain perception and perceived pain during the application of these three invasive techniques.
METHODS
A triple-blinded, pilot randomized controlled trial was conducted on fifteen patients with unilateral PFPS who were randomized to the high-intensity percutaneous electrolysis (HIPE) experimental group, low-intensity percutaneous electrolysis (LIPE) experimental group or DN active control group. All interventions were conducted in the most active MTrP, in the rectus femoris muscle. The HIPE group received a 660 mA galvanic current for 10 s, the LIPE group 220 mA × 30 s and the DN group received no galvanic current. The MTrP and patellar tendon pain pressure thresholds (PPTs) and subjective anterior knee pain perception (SAKPP) were assessed before, after and 7 d after the single intervention. In addition, perceived pain during the intervention was also assessed.
RESULTS
Both groups were comparable at baseline as no significant differences were found for age, height, weight, body mass index, PPTs or SAKPP. No adverse events were reported during or after the interventions. A significant decrease in SAKPP (both HIPE and LIPE,
P
< 0.01) and increased patellar tendon PPT (all,
P
< 0.001) were found, with no differences between the groups (VAS: F = 0.30; η
2
= 0.05;
P
> 0.05; tendon PPT immediate effects: F = 0.15; η
2
= 0.02;
P
> 0.05 and tendon PPT 7-d effects: F = 0.67; η
2
= 0.10;
P
> 0.05). A significant PPT increase in rectus femoris MTrP was found at follow-up in both the HIPE and LIPE groups (both,
P
< 0.001) with no differences between the groups (immediate effects: F= 1.55; η
2
= 0.20;
P
> 0.05 and 7-d effects: F = 0.71; η
2
= 0.10;
P
> 0.05). Both HIPE and LIPE interventions were considered less painful compared with DN (F = 8.52; η
2
= 0.587;
P
< 0.01).
CONCLUSION
HIPE and LIPE induce PPT changes in MTrPs and patellar tendon and improvements in SAKPP, and seem to produce less pain during the intervention compa...
“…Dry needling (DN) is a therapeutic intervention in which thin needles are used to penetrate the skin to affect the underlying connective tissue and neuromuscular system without the use of any medication [1]. DN techniques can be sorted according to the depth that the needle is inserted [2]. Although in recent years it has been associated with other musculoskeletal problems, most commonly, DN is designed for the treatment of myofascial trigger points (MTrPs) [3,4].…”
Procedures such as dry needling (DN) or percutaneous electrical nerve stimulation (PENS) are commonly proposed for the treatment of myofascial trigger points (MTrP). The aim of the present study is to investigate if PENS is more effective than DN in the short term in subjects with mechanical neck pain. This was an evaluator-blinded randomized controlled trial. Subjects were recruited through announcements and randomly allocated into DN or PENS groups. Pain intensity, disability, pressure pain threshold (PPT), range of motion (ROM), and side-bending strength were measured. The analyses included mixed-model analyses of variance and pairwise comparisons with Bonferroni correction. The final sample was composed of 44 subjects (22 per group). Both groups showed improvements in pain intensity (ηp2 = 0.62; p < 0.01), disability (ηp2 = 0.74; p < 0.01), PPT (ηp2 = 0.79; p < 0.01), and strength (ηp2 = 0.37; p < 0.01). The PENS group showed greater improvements in disability (mean difference, 3.27; 95% CI, 0.27–6.27) and PPT (mean difference, 0.88–1.35; p < 0.01). Mixed results were obtained for ROM. PENS seems to produce greater improvements in PPT and disability in the short term.
“…A técnica do agulhamento seco é um procedimento definido como a penetração de uma agulha sólida, realizada sem a introdução de qualquer droga, e tem seu princípio no rompimento mecânico dos pontos-gatilhos miofaciais (PGM) que estão localizados nos músculos esqueléticos, ocasionando a dor. Após a penetração da agulha, ela é estimulada com intuito de se desfazer o nódulo, resultando em um reflexo espinhal involuntário que é a resposta de contração local de fibras musculares afetadas (Griswold et al, 2019).…”
Referido no passado como Síndrome do Minotauro, a hipertrofia do masseter é uma condição relativamente rara, com cerca de 130 casos relatados na literatura, acometendo adultos entre vinte e trinta anos, podendo ser diagnosticado no final da adolescência, sem predisposição por gênero. O paciente pode apresentar entre os achados clínicos uma incapacidade funcional e queixa de desarmonia oclusal, embora na maioria dos casos, a queixa estética é a mais comum. Tem crescimento lento, progressivo, uni ou bilateral e na grande maioria dos casos apresenta ausência de quadro álgico associado. Estudos demostram que a intervenção com o Agulhamento Seco possui benefícios em diversos casos além da dor miofascial, como hemiparesias de membro superior, dedo em gatilho, fibromialgia e disfunções orofaciais. Diante disso o presente estudo teve como objetivo relatar um caso clinico onde a técnica do agulhamento seco foi utilizada para alivio da algia da paciente diagnosticada com hipertrofia dos músculos masseter e temporal, apresentando resultado satisfatório não só no controle da dor como na estética da paciente.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.